CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...